Aster Capital Management’s CVS Health CVS Stock Holding History

Aster Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-29,722	Closed	-$1.95M	–	1146
2025 Q1	$1.95M	Buy	29,722 +29,391	+8,879%	+$1.76M	0.36%	58
2024 Q4	$14.9K	Buy	+331	New	+$18.6K	0.01%	684

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aster Capital Management's CVS Position: Q2 2025 in Review

Aster Capital Management sold out of CVS Health (CVS) in Q2 2025, closing a stake of 29,722 shares — an estimated $1.95M sold.

Aster Capital Management first reported a position in CVS in Q4 2024 and held it in 2 quarters. The position peaked at $1.95M in Q1 2025. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

Aster Capital Management reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
Aster Capital Management sold 29,722 CVS Health shares in Q2 2025, an estimated $1.95M.
Aster Capital Management first reported a position in CVS Health in Q4 2024 and held it in 2 quarters.
Aster Capital Management's CVS Health position peaked at $1.95M in Q1 2025.
1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Aster Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.